Literature DB >> 17499440

Fertility issues in survivors from adolescent cancers.

A A Pacey1.   

Abstract

Infertility is a common and distressing late-effect of cancer treatment. Whist sperm banking for post-pubertal males and embryo freezing for women (who are in a stable relationship at the time of treatment) are highly successful fertility preservation strategies, for females without a partner (including young and pre-pubescent girls) and pre-pubescent boys (or azoospermic men), there remain no effective approaches. Whilst the biological effects of cancer treatments on the reproductive system are well described, there are few data on the relative incidence of infertility (failure to conceive after one year of trying) in cancer survivors. This makes it difficult to advise survivors about their future fertility prospects. Whilst some will undoubtedly conceive naturally with their partner, others will require assisted conception treatment of which in vitro fertilisation (IVF) and intra-cytoplasmic sperm injection (ICSI) are the most common. Pregnancy outcomes of cancer survivors are generally good, although there is increased risk of pre-term birth and low birth-weight in the offspring of women who have received pelvic irradiation. There is no increased incidence of genetic disease or cancer incidence in the offspring of cancer survivors. Current research directions are focussing on alternative fertility preservation strategies including in vitro maturation techniques, xenotransplantation and the development of technology to create artificial gametes in the laboratory. Finally, although the reproductive techniques discussed are highly effective, country specific differences in the legal framework means that cancer survivors may be denied access to certain treatments (e.g. embryo cryopreservation) because they are forbidden by specific national legislation.

Entities:  

Mesh:

Year:  2007        PMID: 17499440     DOI: 10.1016/j.ctrv.2007.02.001

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  16 in total

1.  Routine cryopreservation of spermatozoa is safe--evidence from the DNA methylation pattern of nine spermatozoa genes.

Authors:  Ruth Kläver; Andreas Bleiziffer; Klaus Redmann; Con Mallidis; Sabine Kliesch; Jörg Gromoll
Journal:  J Assist Reprod Genet       Date:  2012-06-13       Impact factor: 3.412

Review 2.  Measuring the psychosocial health of adolescent and young adult (AYA) cancer survivors: a critical review.

Authors:  Tara Clinton-McHarg; Mariko Carey; Rob Sanson-Fisher; Anthony Shakeshaft; Kathy Rainbird
Journal:  Health Qual Life Outcomes       Date:  2010-03-06       Impact factor: 3.186

3.  Young Adult Female Cancer Survivors' Concerns About Future Children's Health and Genetic Risk.

Authors:  Nirupa Jaya Raghunathan; Catherine Benedict; Bridgette Thom; Danielle Novetsky Friedman; Joanne Frankel Kelvin
Journal:  J Adolesc Young Adult Oncol       Date:  2018-01-24       Impact factor: 2.223

Review 4.  Fertility preservation strategies for male patients with cancer.

Authors:  Darren J Katz; Thomas F Kolon; Darren R Feldman; John P Mulhall
Journal:  Nat Rev Urol       Date:  2013-07-09       Impact factor: 14.432

5.  Tamoxifen decreases ovarian follicular loss from experimental toxicant DMBA and chemotherapy agents cyclophosphamide and doxorubicin in the rat.

Authors:  Alison Y Ting; Brian K Petroff
Journal:  J Assist Reprod Genet       Date:  2010-08-14       Impact factor: 3.412

6.  Fertility Preservation Options for Men and Women With Cancer.

Authors:  Malgorzata E Skaznik-Wikiel; Sara Babcock Gilbert; Randall B Meacham; Laxmi A Kondapalli
Journal:  Rev Urol       Date:  2015

7.  Implications of sperm banking for health-related quality of life up to 1 year after cancer diagnosis.

Authors:  A Pacey; H Merrick; E Arden-Close; K Morris; R Rowe; D Stark; C Eiser
Journal:  Br J Cancer       Date:  2013-03-07       Impact factor: 7.640

Review 8.  Fertility preservation during cancer treatment: clinical guidelines.

Authors:  Kenny A Rodriguez-Wallberg; Kutluk Oktay
Journal:  Cancer Manag Res       Date:  2014-03-04       Impact factor: 3.989

Review 9.  Fertility-preserving treatment options in patients with malignant hematological diseases.

Authors:  Mert Küçük; Ali Zahit Bolaman; Irfan Yavaşoğlu; Gürhan Kadıköylü
Journal:  Turk J Haematol       Date:  2012-10-05       Impact factor: 1.831

Review 10.  Contemporary and future insights into fertility preservation in male cancer patients.

Authors:  Ashok Agarwal; Chloe Ong; Damayanthi Durairajanayagam
Journal:  Transl Androl Urol       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.